EPO and Abnormal retinal morphology: Hence, before the extension to the in vivo studies to further verify the MSC-EPO-mediated neuroprotective activity in a retinal disease animal model, it is vital to establish a stable clone of transduced MSC-EPO and determine the minimal amount of EPO sufficient to exert the neuroprotective action.